Alternate-day, low-dose aspirin and cancer risk
- PMID: 23856684
- DOI: 10.7326/0003-4819-159-2-201307160-00013
Alternate-day, low-dose aspirin and cancer risk
Comment on
-
Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.Ann Intern Med. 2013 Jul 16;159(2):77-85. doi: 10.7326/0003-4819-159-2-201307160-00002. Ann Intern Med. 2013. PMID: 23856681 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical